Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Market Cap	96.43B -2.9%
Revenue (ttm)	77.80B -24.4%
Net Income	12.94B -42.1%
EPS	2,120.00 -42.1%
Shares Out	6.10M
PE Ratio	7.45
Forward PE	n/a
Dividend	800.00 (5.03%)
Ex-Dividend Date	Dec 29, 2025

Volume	4,278
Average Volume	5,628
Open	15,760
Previous Close	15,900
Day's Range	15,520 - 15,860
52-Week Range	14,730 - 19,250
Beta	0.22
RSI	49.52
Earnings Date	Nov 14, 2025

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Industry: Pharmaceutical Preparations
• Founded: 1945
• Employees: 300
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2024, Sam-A Pharm.'s revenue was 95.58 billion, a decrease of -1.68% compared to the previous year's 97.21 billion. Earnings were 22.08 billion, an increase of 3.30%.